Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance

Only a subset of cancer patients respond to T-cell checkpoint inhibitors, highlighting the need for alternative immunotherapeutics. We performed CRISPR-Cas9 screens in a leukemia cell line to identify perturbations that enhance natural killer effector functions. Our screens defined critical componen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:eLife
Main Authors: Pech, Matthew F, Fong, Linda E, Villalta, Jacqueline E, Chan, Leanne JG, Kharbanda, Samir, O'Brien, Jonathon J, McAllister, Fiona E, Firestone, Ari J, Jan, Calvin H, Settleman, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado em: eLife Sciences Publications, Ltd 2019
Assuntos:
Cancer Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713475/
https://ncbi.nlm.nih.gov/pubmed/31452512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.47362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados